Literature DB >> 16867733

Dissolution test for felodipine tablets using chemical oxidation in situ to maintain 'sink conditions'.

K Felle1, B Persson, J Vessman.   

Abstract

A test model is described for the determination of the dissolution rate of the vasodilator, felodipine, a derivative of dihydropyridine that is practically insoluble in water. 'Sink conditions' are maintained by means of an oxidizing agent, ceric sulphate, which reacts rapidly with dissolved drug molecules in the dissolution fluid. A pyridine derivative is formed quantitatively in the oxidation reaction. The amount of dissolved felodipine is calculated from the concentration of the pyridine derivative, as determined by reversed-phase liquid chromatography. Dissolution rates depend on the concentration of the oxidizing agent so that high concentrations accelerate dissolution. The dissolution test suggested for 25-mg felodipine tablets is performed in 500 ml fluid that contains 5 mM ceric sulphate in 0.12 M sulphuric acid. The test is performed on single tablets with USP paddle equipment. Dissolution rates for nine different tablet compositions are correlated to such bioavailability parameters as maximum plasma concentration and total area under the plasma concentration-time curve. Interferences and limitations of the method are discussed.

Entities:  

Year:  1984        PMID: 16867733     DOI: 10.1016/0731-7085(84)80056-4

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  4 in total

1.  Plasma concentration profiles and antihypertensive effect of conventional and extended-release felodipine tablets.

Authors:  E Blychert; K Wingstrand; B Edgar; K Lidman
Journal:  Br J Clin Pharmacol       Date:  1990-01       Impact factor: 4.335

Review 2.  Felodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.

Authors:  E Saltiel; A G Ellrodt; J P Monk; M S Langley
Journal:  Drugs       Date:  1988-10       Impact factor: 9.546

Review 3.  Clinical pharmacokinetics of felodipine. A summary.

Authors:  B Edgar; P Lundborg; C G Regårdh
Journal:  Drugs       Date:  1987       Impact factor: 9.546

4.  A Physiologically Based Pharmacokinetic and Pharmacodynamic Model of the CYP3A4 Substrate Felodipine for Drug-Drug Interaction Modeling.

Authors:  Laura Maria Fuhr; Fatima Zahra Marok; Maximilian Mees; Felix Mahfoud; Dominik Selzer; Thorsten Lehr
Journal:  Pharmaceutics       Date:  2022-07-15       Impact factor: 6.525

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.